Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | N/A | N/A | 736 | N/A | N/A |
| Other Investing Activity | 1,153 | 920 | 2,093 | -208 | 1,378 |
| Investing Cash Flow | $1,153 | $920 | $2,829 | $-208 | $1,378 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,192 | 3,924 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 1,770 | 7,100 | 10,619 |
| Common Stock Repurchased | -2 | N/A | N/A | N/A | -88 |
| Financing Cash Flow | $3,190 | $3,924 | $1,770 | $7,100 | $10,531 |
| Exchange Rate Effect | -16 | 146 | 50 | 311 | -19 |
| Beginning Cash Position | 586 | -15 | 2,746 | 4,971 | 1,697 |
| End Cash Position | 6 | 586 | 146 | 2,746 | 4,971 |
| Net Cash Flow | $-564 | $455 | $-2,650 | $-2,535 | $3,293 |
| Free Cash Flow | |||||